At the time, I never imagined I would get a 'blood disease'.Until then, I had been working normally, living with my family, ...

Presentations feature real-world experience and clinical evidence in lower-risk MDS, underscoring growing global scientific engagement with ...

Myelodysplastic syndromes (MDS) belong to the malignant diseases of the hematopoietic system that occur primarily in older ...

Myelodysplastic syndromes (MDS) are treated based on type and risk assessment, but traditional therapies may not work for everyone. Clinical trials offer a way to explore emerging treatments and ...

Dr. Shaal Patel, a board certified physician in hematology, oncology, and internal medicine, spoke with Healthline about how myelodysplastic syndromes (MDS) can benefit from supportive therapy, ...

A panel of experts discuss the complex nature of myelodysplastic syndromes and concurrent subclassifications. At the start, we’re going to lean heavily on Dr Zeidan because we want to have a good ...

Panelists share insight on therapeutic goals when treating patients with myelodysplastic syndromes. Bruce Feinberg, DO: Amer, when we’re initiating, whether it’s ESAs [erythropoietin-stimulating ...

Physician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have published a review in the Journal of the American Medical Association that ...

Physician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have published a review in the Journal of the American Medical Association that ...

Successful Management of Neutropenic Sepsis Is Key to Better Survival of Patients With Blood Cancer in Sri Lanka: Real-World Data From the Resource-Limited Setting Myelodysplastic syndromes (MDS) ...